Key result
Adolescent SARS-CoV-2 perimyocarditis with severe dysfunction recovers to ~52% LVEF by 3 months.
Why the study?
SARS-CoV-2 associated with COVID-19 infection has emerged as a potential rare viral cause of perimyocarditis.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
Documents CMR recovery in adolescent SARS-CoV-2 perimyocarditis; hypothesis-generating and leaves management unchanged pending larger studies.
Perimyocarditis is a well-known acute inflammation of the pericardium and the underlying myocardium. Most commonly perimyocarditis is of viral aetiology, specifically the coxsackie B virus. However, nowadays SARS-CoV-2 associated with COVID-19 infections has emerged as a potential rare cause of perimyocarditis. This case report will demonstrate a case of a young female with perimyocarditis as diagnosed by magnetic resonance imaging (MRI) accompanied by antigens indicating a past COVID-19 infection. Clinical status as well as Findings at MRI, echocardiography and lab results will be reviewed.
No takes yet. Share an insight, caveat, or question.
Driest et al. (2021) conducted a case report in COVID-19 associated perimyocarditis (n=1). SARS-CoV-2 infection was evaluated. SARS-CoV-2-associated perimyocarditis in a 15-year-old female presented with LVEF of 38% and troponin of 87 ng/L, recovering to an LVEF of 52% with normalized T1/T2 mapping at 3 months.
Synapse has enriched 10 related papers. Consider them for comparative context: